Cargando…
Diagnostic accuracy of CD44V6 for osteosarcoma: a meta-analysis
BACKGROUND: Recently, more and more evidences have revealed the association between CD44V6 and osteosarcoma (OS), but whether it can be used as a clinical biomarker is still unknown. The purpose of this study is to assess the diagnostic value of CD44V6 in OS by conducting a meta-analysis. METHODS: A...
Autores principales: | Zhang, Yunyuan, Lun, Limin, Zhu, Baozhi, Wang, Qing, Ding, Chunming, Hu, Yanlin, Huang, Weili, Zhou, Lan, Chen, Xian, Huang, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094028/ https://www.ncbi.nlm.nih.gov/pubmed/27809879 http://dx.doi.org/10.1186/s13018-016-0470-2 |
Ejemplares similares
-
Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis
por: Zhang, Yunyuan, et al.
Publicado: (2015) -
The Prognostic Significance of CD44V6, CDH11, and β-Catenin Expression in Patients with Osteosarcoma
por: Deng, Zhouming, et al.
Publicado: (2013) -
CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008) -
Prognostic role of CD44 expression in osteosarcoma: evidence from six studies
por: Liu, Yu, et al.
Publicado: (2014) -
CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2022)